Scleroderma News and Research

RSS
Scleroderma is a chronic, often progressive, autoimmune disease in which the body's immune system attacks its own body. The disease, which literally means "hard skin," can cause a thickening and tightening of the skin. In some cases it causes serious damage to internal organs including the lungs, heart, kidneys, esophagus and gastrointestinal tract. Some medicines and treatments can help with certain symptoms, but there is still no cure for scleroderma, which affects about 300,000 nationwide. (By way of comparison, about 50,000 people have muscular dystrophy, 250,000 are estimated to have lupus and 350,000 have multiple sclerosis.)
CPF proclaims September as 'Pulmonary Fibrosis Awareness Month'

CPF proclaims September as 'Pulmonary Fibrosis Awareness Month'

Researchers identify Wnt pathway as new target for scleroderma therapy

Researchers identify Wnt pathway as new target for scleroderma therapy

Molecular secrets behind halofuginone's power

Molecular secrets behind halofuginone's power

Northwestern researchers receive NIAMSD grant to study scleroderma

Northwestern researchers receive NIAMSD grant to study scleroderma

HHS scientists to share recent rheumatology findings at 75th ACR annual meeting

HHS scientists to share recent rheumatology findings at 75th ACR annual meeting

Psychological stress can trigger flares of vasculitis

Psychological stress can trigger flares of vasculitis

BUSM researcher receives two NIH grants to study scleroderma

BUSM researcher receives two NIH grants to study scleroderma

Promedior's Pentraxin-2 effectively suppresses liver fibrosis

Promedior's Pentraxin-2 effectively suppresses liver fibrosis

Bortezomib drug may also treat pulmonary fibrosis or scleroderma

Bortezomib drug may also treat pulmonary fibrosis or scleroderma

Bristol-Myers Squibb acquires Amira Pharmaceuticals

Bristol-Myers Squibb acquires Amira Pharmaceuticals

UTHealth inaugurates new center for autoimmune and inflammatory diseases research

UTHealth inaugurates new center for autoimmune and inflammatory diseases research

FDA panel on post-approval studies of silicone breast implants

FDA panel on post-approval studies of silicone breast implants

Roche Canada grants Vasculitis and Scleroderma Fellowship

Roche Canada grants Vasculitis and Scleroderma Fellowship

U-M skilled physician named as Scleroderma Foundation's Doctor of the Year

U-M skilled physician named as Scleroderma Foundation's Doctor of the Year

W.M. Keck Foundation awards Jefferson scientists with $1M medical research grant

W.M. Keck Foundation awards Jefferson scientists with $1M medical research grant

Bristol-Myers Squibb signs definitive agreement to acquire Amira Pharmaceuticals

Bristol-Myers Squibb signs definitive agreement to acquire Amira Pharmaceuticals

Three factors contribute to systemic scleroderma-related work disability

Three factors contribute to systemic scleroderma-related work disability

U.S. Senators introduce Pulmonary Fibrosis Research Enhancement Act

U.S. Senators introduce Pulmonary Fibrosis Research Enhancement Act

Study reports high prevalence of vitamin D insufficiency in patients with psoriatic arthritis

Study reports high prevalence of vitamin D insufficiency in patients with psoriatic arthritis

Flamel, Digna Biotech enter joint development agreement for multiple products

Flamel, Digna Biotech enter joint development agreement for multiple products